| Vol. 6.21 – 21 June, 2021 |
| |
|
|
| Scientists generated human induced pluripotent stem cells (hiPSCs) carrying a TNNI1EmGFP and TNNI3mCherry double reporter to monitor and isolate mature sub-populations during cardiac differentiation, and showed that ERRγ-treated hiPSC-cardiomyocytes (CMs) had a mature cellular property consistent with neonatal CMs. [Nature Communications] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
| |
|
|
| The authors investigated the role and underlying molecular basis of osteocrin (OSTN) in diabetic cardiomyopathy. Neonatal rat cardiomyocytes were isolated and stimulated with high glucose to verify the role of OSTN in vitro. [Cell Death & Disease] |
|
|
|
| Researchers investigated the protective effect of emodin on septic myocardial injury and the underlying mechanism. Lipopolysaccharide (LPS)-induced C57BL/6 mice and cardiomyocytes were used as models of sepsis in vivo and in vitro, respectively. [Phytotherapy Research] |
| |
|
|
| Investigators showed that survival motor neuron (SMN)-deficient myoblasts readily fused with wild-type myoblasts, demonstrating fusion competency. Conditioned media from wild type differentiating myoblasts did not rescue the fusion deficit of SMN-deficient cells, suggesting that compromised fusion may have primarily been a result of altered membrane dynamics at the cell surface. [Journal of Cachexia Sarcopenia and Muscle] |
|
|
|
| In an immortalized patient myoblast cell line, researchers demonstrated that targeting DUX4 led to substantial downregulation of not only pathogenic DUX4 transcripts, but also a subset of its target genes that are known biomarkers of facioscapulohumeral muscular dystrophy. [Scientific Reports] |
|
|
|
| In an in vitro model of myogenesis, the expression of nTRIP6 was transiently up-regulated at the transition between proliferation and differentiation, whereas that of the cytosolic isoform TRIP6 was not altered. [Scientific Reports] |
|
|
|
| The authors investigated the contribution of the tissue-specific erythropoietin (EPO)-receptor (EpoR) to exercise-induced remodeling of cardiac and skeletal muscle and indicated that the endogenous EPO-EpoR system controlled mitochondrial biogenesis in skeletal muscle. [Pflugers Archiv-European Journal of Physiology] |
| |
|
|
| Using human vascular smooth muscle cells (VSMCs) treated by oxidized low-density lipoprotein to establish an atherosclerosis cell model, scientists explored the functional roles and molecular mechanisms of miR-141-5p in VSMCs dysfunction. [Journal of Biochemical and Molecular Toxicology] |
|
|
|
| Electrophysiological recordings were performed in freshly isolated coronary arterial smooth muscle cells to investigate the inhibitory effect of olanzapine on voltage-dependent K+ channels. [Pharmacological Reports] |
|
|
|
| Researchers investigated the role of high shear stress (HSS) in atherosclerotic plaque formation. In vitro modeling used human umbilical vein endothelial cells and vascular smooth muscle cells exposed to HSS using a parallel‑plate flow system. [Molecular Medicine Reports] |
|
|
|
|
| The authors discuss the action of signaling pathways in the control of cardiomyocyte differentiation timing, including the Wnt, Fibroblast Growth Factor, Hedgehog, Bone Morphogenetic Protein, Insulin-like Growth Factor, Thyroid Hormone and Hippo pathways. [Seminars in Cell & Developmental Biology] |
|
|
|
| Scientists present the interactions that leukocytes develop with the cells present in their vicinity, such as the activation of muscle stem cells and the maturation of newly formed myofibers, and the impact they have on skeletal muscle regeneration. [Seminars in Cell & Developmental Biology] |
|
|
|
| Investigators provide a detailed overview of the pathways and metabolic routes that can be modulated to halt and redirect their fibro/adipogenic potential while favoring their supportive role in muscle regeneration. [FEBS Journal] |
|
|
|
|
| The annual Vagelos Precision Medicine Pilot Grants have been awarded to five teams of VP&S researchers conducting innovative basic science, translational, and clinical research across multiple diseases, from novel cancer therapeutics to health disparities research. [Columbia University Irving Medical Center] |
|
|
|
|
| October 6 – 8, 2021 Virtual |
|
|
|
|
|
| Oklahoma Medical Research Foundation – Oklahoma City, Oklahoma, United States |
|
|
|
| Hannover Medical School – Hannover, Germany |
|
|
|
|
University of Nebraska Medical Center – Omaha, Nebraska, United States |
| | Harvard T.H. Chan School of Public Health – Boston, Massachusetts, United States |
|
|
|
| Johannes Gutenberg University Mainz – Mainz, Germany |
|
|
|
|